Tignor Michael Brent 4
4 · BALCHEM CORP · Filed Mar 12, 2024
Insider Transaction Report
Form 4
BALCHEM CORPBCPC
Tignor Michael Brent
SVP & Chief HR Officer
Transactions
- Sale
Common Stock
2024-03-08$158.22/sh−2,078$328,788→ 8,368 total - Exercise/Conversion
Stock Options (right to buy)
2024-03-08−4,200→ 4,200 totalExercise: $85.40Exp: 2027-02-21→ Common Stock (4,200 underlying) - Exercise/Conversion
Common Stock
2024-03-08$85.40/sh+4,200$358,680→ 13,707 total - Sale
Common Stock
2024-03-08$157.07/sh−3,261$512,197→ 10,446 total
Footnotes (5)
- [F1]Exercise of fully vested non-qualified stock options.
- [F2]Includes acquisition of shares (company match) under the Balchem Corporation 401(k) plan.
- [F3]This transaction was executed in multiple sales ranging from $157.0000 to $157.1900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- [F4]This transaction was executed in multiple sales ranging from $158.0000 to $158.7850 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- [F5]Stock options that vested 20% on February 21, 2018, 40% on February 21, 2019, and 40% on February 21, 2020, and are exercisable.